• 1
    Lelbach WK. Liver damage in chronic alcoholism. Results of a clinical, clinical-chemical and bioptic-histological study in 526 alcoholic patients during a low-calorie diet in an open drinking sanatorium. Acta Hepatosplenol 1966; 13: 321349.
  • 2
    Diehl AM. Liver disease in alcohol abusers: clinical perspective. Alcohol 2002; 27: 711.
  • 3
    You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002; 277: 2934229347.
  • 4
    Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003; 278: 2799728004.
  • 5
    You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 2004; 127: 17988084.
  • 6
    Ji C, Chan C, Kaplowitz N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol 2006; 45: 717724.
  • 7
    Chen X, Sebastian BM, Nagy LE. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am J Physiol Endocrinol Metab 2007; 292: E621E628.
  • 8
    Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91100.
  • 9
    You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. HEPATOLOGY 2005; 42: 568577.
  • 10
    Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, Bain RP, et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterol 1981; 81: 668675.
  • 11
    Mato JM, Alvarez L, Corrales J. S-adenosylmethionine and the liver. In: Arias IM, ed. The Liver: Biology and Pathobiology. New York: Raven Press, 1997: 461470.
  • 12
    Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003; 124: 14881499.
  • 13
    Kharbanda KK, Rogers DD 2nd, Mailliard ME, Siford GL, Barak AJ, Beckenhauer HC, et al. Role of elevated S-adenosylhomocysteine in rat hepatocyte apoptosis: protection by betaine. Biochem Pharmacol 2005; 70: 18831890.
  • 14
    Song Z, Zhou Z, Uriarte S, Wang L, Kang YJ, Chen T, et al. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease. HEPATOLOGY 2004; 40: 989997.
  • 15
    Halsted CH, Villanueva J, Chandler CJ, Stabler SP, Allen RH, Muskhelishvili L, et al. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. HEPATOLOGY 1996; 23: 497505.
  • 16
    Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 17841792.
  • 17
    Frayn KN. Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 2005; 64: 713.
  • 18
    Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3–L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 1992; 52: 41134116.
  • 19
    Alvarez B, Carbo N, Lopez-Soriano J, Drivdahl RH, Busquets S, Lopez-Soriano FJ, et al. Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochim Biophys Acta 2002; 1570: 3337.
  • 20
    Viswanadha S, Londos C. Optimized conditions for measuring lipolysis in murine primary adipocytes. J Lipid Res 2006; 47: 18591864.
  • 21
    Lieber CS, De Carli LM. Ethanol dependence and tolerance: a nutritionally controlled experimental model in the rat. Res Commun Chem Pathol Pharmacol 1973; 6: 983991.
  • 22
    Woo CW, Siow YL, Pierce GN, Choy PC, Minuk GY, Mymin D, et al. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am J Physiol Endocrinol Metab 2005; 288: E1002E1010.
  • 23
    Murthy SN, Obregon DF, Chattergoon NN, Fonseca NA, Mondal D, Dunne JB, et al. Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet. Metabolism 2005; 54: 645652.
  • 24
    Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 264280.
  • 25
    Mato JM, Lu SC. Homocysteine, the bad thiol. HEPATOLOGY 2005; 41: 976979.
  • 26
    Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52: 16551663.
  • 27
    Park SK, Oh SY, Lee MY, Yoon S, Kim KS, Kim JW. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 2004; 53: 27572766.
  • 28
    Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, et al. C/EBPα regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 2005; 54: 17441754.
  • 29
    Seo JB, Moon HM, Noh MJ, Lee YS, Jeong HW, Yoo EJ, et al. Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J Biol Chem 2004; 279: 2210822117.
  • 30
    Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901911.
  • 31
    Chevillotte E, Giralt M, Miroux B, Ricquier D, Villarroya F. Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production. Diabetes 2007; 56: 10421050.
  • 32
    Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor γ (PPARγ) and C/EBPα gene expression during the differentiation of 3T3–L1 preadipocytes. J Biol Chem 2002; 277: 4622646232.
  • 33
    Sale EM, Atkinson PG, Sale GJ. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 1996; 14: 674684.
  • 34
    Bost F, Aouadi M, Caron L, Binetruy B. The role of MAPKs in adipocyte differentiation and obesity. Biochimie (Paris) 2005; 87: 5156.
  • 35
    Robert K, Pages C, Ledru A, Delabar J, Caboche J, Janel N. Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 2005; 133: 925935.
  • 36
    Hamelet J, Demuth K, Delabar JM, Janel N. Inhibition of extracellular signal-regulated kinase in liver of hyperhomocysteinemic mice. Arterioscler Thromb Vasc Biol 2006; 26: e126e127.
  • 37
    Kharbanda KK, Mailliard ME, Baldwin CR, Beckenhauer HC, Sorrell MF, Tuma DJ. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol 2007; 46: 314321.